Vaxart Investors Seek Initial OK Of $12M Deal In Fraud Suit
A proposed class of investors in Vaxart has urged a California federal court to give its initial OK to a $12 million settlement with the biotechnology company over allegations it pumped...To view the full article, register now.
Already a subscriber? Click here to view full article